Polycystic Ovarian Disease or Polycystic Ovarian Syndrome How To Identify and Manage A Review
Polycystic Ovarian Disease or Polycystic Ovarian Syndrome How To Identify and Manage A Review
School of Medical and Allied Sciences, K.R. Mangalam University, Sohna Road, Gurugram, Haryana, India.
Abstract
PCOD or PCOS is a reproductive and metabolic disorder concerned with the ovaries. An ovary is an active organ that changes its form,
appearance, and shape according to its hormonal ambiance. PCOD or PCOS is a condition in which ovary of women of childbearing age is
enlarged and starts producing an excessive amount of male hormones (androgens) and is the main cause of infertility, diabetes, irregular
menstrual periods, and hirsutism. No exact cause of the disease has been found yet but the change in lifestyle, change in dietary needs, lack
of exercise, and the most important of all, i.e. stress level induces the disease. There are medicines, which can induce an artificial menstrual
cycle and regulate the level of hormones and ultimately treat the three signs of PCOS i.e. Acne, Hirsutism, and Obesity.
INTRODUCTION
PCO (Polycystic ovary) is a condition and PCOS
(Polycystic ovary syndrome) is a symptom [1, 2]. A pattern of
symptoms belonging to a particular disease is defined as a
syndrome [3]. Ovary of normal women who is in the age of
her reproductive years has a volume of around 4-6 ml of
each ovary and have a folded structure like a walnut, but if a
woman is diagnosed with PCOS, her ovaries get enlarged
and bulky with having more than 10 ml of volume, thus it
starts producing a high quantity of androgens [4-10].
include resistance towards insulin, an increase in the level of 15. Dunaif A. Insulin resistance and the polycystic ovary syndrome:
Mechanism and implications for pathogenesis. Endocr Rev.
androgen production, and altered gonadotropin dynamics. It
1997;18(6):774–800.
is also associated with an imbalance in glucose and insulin 16. Thomson RL, Teede HJ, Stepto NK, Banting LK, Moran LJ. 2 The
dysfunction, which leads to obesity, diabetes, a rise in Role of Diet and Lifestyle Modification in the Treatment of
cholesterol level and an increase in blood pressure. Stress is Polycystic Ovary Syndrome. InNutrition, Fertility, and Human
Reproductive Function 2015 Feb 24 (pp. 42-65). CRC Press.
one of the primary causes of PCOS, which can ultimately 17. Goodarzi MO et al. Polycystic ovary syndrome: Etiology,
lead to hypertension, diabetes mellitus, increased risk of pathogenesis, and diagnosis. Nat Rev Endocrinol. 2011;7(4):219–
uterine cancer, and even cardiovascular diseases. 231.
Endocrine features related to the diagnosis of PCOS or 18. Teede HJ et al. Assessment and management of polycystic ovary
syndrome: Summary of an evidence-based guideline. Med J Aust.
PCOD include elevated levels of certain hormones like 2011;195(6): S65–S112.
androgens, luteinizing hormone, prolactin, and estrogen. 19. Teede H, Hutchison SK, Zoungas S. The management of insulin
Diagnostic criteria of the disease are having two out of the resistance in polycystic ovary syndrome. Trends Endocrinol Metab.
following symptoms: Hyperandrogenism, Oligomenorrhoea, 2007;18(7):273–279.
20. Jassim WH, Al-Obaidi MT, Abdulhameed WA. The Effect of
or Polycystic appearance of the ovaries. Infertility,
Insulin Resistance on Oocyte Maturation and Embryo Quality in
menstrual disturbances, and acne can be prevented by taking PCOS Patients Undergoing ICSI. Int. J. Pharm. Phytopharm. Res.
oral contraceptives, insulin lowering drugs, progestin 2019;9(1):36-42.
therapy, and weight loss. 21. Polycystic Ovary Syndrome: A woman’s guide to identifying and
managing PCOS, Dr. John Eden; 2005:172.
22. Guzick David, Polycystic ovary syndrome: Symptomatology,
REFERENCES pathophysiology, and epidemiology;1998:S89-S93.
23. Polycystic Ovary Syndrome: A woman’s guide to identifying and
1. Polycystic Ovary Syndrome: A woman’s guide to identifying and
managing PCOS, Dr. John Eden; 2005:48-49.
managing PCOS, Dr. John Eden; 2005:1.
24. Moran LJ et al. Impaired glucose tolerance, type 2 diabetes and
2. Osman NN, Alsahfi SA, Alshubaily F. Effectiveness of Aqueous
metabolic syndrome in polycystic ovary syndrome: A systematic
Extract of Fenugreek Seeds and Flaxseed on Polycystic Ovarian
review and meta-analysis. Hum Reprod Update. 2010;16(4):347–
Syndrome in Female Rats. Int. J. Pharm. Res. Allied Sci.
363.
2019;8(4):42-54.
25. Wild RA et al. Assessment of cardiovascular risk and prevention of
3. Polycystic Ovary Syndrome: A woman’s guide to identifying and
cardiovascular disease in women with the polycystic ovary
managing PCOS, Dr. John Eden; 2005:4.
syndrome: A consensus statement by the Androgen Excess and
4. Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in
Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol
women with anovulation and idiopathic hirsutism. Br Med J (Clin
Metab. 2010;95(5):2038–2049.
Res Ed) 1986;293:355-9
26. Polycystic Ovary Syndrome: A woman’s guide to identifying and
5. Balen A. Pathogenesis of polycystic ovary syndrome–the enigma
managing PCOS, Dr. John Eden; 2005:43-45.
unravels? Lancet 1999;354:966-7
27. DuRant Elizabeth, Polycystic Ovary Syndrome: A Review of
6. Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic
Current Knowledge; The Journal for Nurse Practitioners;2007:180-
ovaries and associated clinical and biochemical features in young
185.
women. Clin Endocrinol (Oxf) 1999;51:779-86
28. Polycystic Ovary Syndrome: A woman’s guide to identifying and
7. Legro RS. Polycystic ovary syndrome: current and future treatment
managing PCOS, Dr. John Eden; 2005:183-185.
paradigms. Am J Obstet Gynecol 1998;179(Suppl):101-8
29. Ashtiani AR, Vahidian-Rezazadeh M, Jafari M, Galdavi R,
8. Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of
Mohammad M. Study of Changes in The Plasma Levels of
polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004;60:1-17
Chemerin of Women with Overweight and Obese During a Period of
9. Balen AH. Is metformin the treatment of choice for anovulation in
Endurance Training On a Cycle-Ergometer Using Hydroalcoholic
polycystic ovary syndrome? Nat Clin Pract Endocrinol Metab
Extract of Urtica. Pharmacophores. 2018;9(2):72-9.
2007;3:440-1
30. Azziz Ricardo, Reproductive BioMedicine Online; PCOS: a
10. Poordast T, Alborzi T, Askari E, Samsami A, Najib FS, Hamedi M,
diagnostic challenge;2004 (8):644-648.
Naghmeh Sanj Z. A Rare Case of Tubo-Ovarian Abscess by
31. Alnahdi HS. The Possible Ameliorative Mechanisms of Curcumin
Enterococcus SPP, Following Intrauterine Insemination. Int. J.
and/or Coenzyme Q10 Against Hyperthyroidism Induced Liver
Pharm. Phytopharm. Res. 2019;9(2):32-5.
Damage in Rats. Entomol. appl. sci. lett. 2018;5(1):7-16.
11. Polycystic Ovary Syndrome: A woman’s guide to identifying and
32. Polycystic Ovary Syndrome: A woman’s guide to identifying and
managing PCOS, Dr. John Eden; 2005:3.
managing PCOS, Dr. John Eden; 2005:55-56.
12. PonJola Coney, Polycystic ovarian disease: current concepts of
33. Polycystic Ovary Syndrome: A woman’s guide to identifying and
pathophysiology and therapy, Fertility And Sterility;1984 (42): 667-
managing PCOS, Dr. John Eden; 2005:19-24.
680
34. Polycystic Ovary Syndrome: A woman’s guide to identifying and
13. Polycystic Ovary syndrome, Gabor T. Kovacs and Robert Norman,
managing PCOS, Dr. John Eden; 2005:73-75.
Cindy Farquhar; 2007:4-7.
35. Polycystic Ovary Syndrome: A woman’s guide to identifying and
14. Stepto NK et al. Women with polycystic ovary syndrome have
managing PCOS, Dr. John Eden; 2005:103-115.
intrinsic insulin resistance on euglycaemichyperinsulaemic clamp.
36. Cindy Farquhar, Introduction and history of polycystic ovary
Hum Reprod. 2013;28(3):777–784.
syndrome; 2007:4-13.